active pharmaceutical ingredients, affordable healthcare, bayer, cancer treatment, cdsco, central drugs standard control organisation, clinical trials, coronavirus, fope, good manufacturing practices, health, health ministry, india drug regulatory authority, insulin aspart, journalist, journalists, minimum import price, msmes in pharma, national pharmaceutical pricing authority, news, novo nordisk, pharma, pharmaceutical industry, schedule m compliance, union health ministry